Physician profile
Erin Meisel
NPI 1013350818
$5,013.35
in general payments reported to CMS, 2019-2025
9 companies · $2,288 in 2025
The $2,288 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $150 · 2022: $353 · 2023: $239 · 2024: $1,866 · 2025: $2,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,696 · Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,696.21 |
| Food and Beverage | $1,697.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $3,710.26 | 2024-2025 | Checkpoint Stimulators |
| Depuy Synthes Sales INC. | $388.02 | 2022-2023 | Dynacord, Quickanchor Orthocord, Quickanchor Ethibond |
| Axogen | $202.47 | 2025 | |
| Integra Lifesciences Corporation | $164.85 | 2022 | |
| Osteomed LLC | $150.00 | 2021 | |
| Stryker Corporation | $127.12 | 2022-2025 | Pangea, Axsos |
| Acumed LLC | $117.31 | 2019 | |
| Medartis INC. | $107.78 | 2025 | Aptus |
| Trimed, INC. | $45.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Meisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.